Los Alamos National Laboratory

Los Alamos National Laboratory

Delivering science and technology to protect our nation and promote world stability
Find Expertise logo

Profile Pages

View homepages for scientists and researchers. Explore potential collaborations and project opportunities. Search the extensive range of capabilities by keyword to quickly find who and what you are looking for.

Elizabeth Hong-Geller

Elizabeth Hong-Geller

Phone (505) 665-2465


  • Biosciences
  • Biosecurity
  • Pre-symptomatic diagnosis of infection,
  • Vaccines and therapeutics for infectious diseases
  • Pathogen studies
  • Biological threat identification, characterization, detection/diagnosis,
  • Biological countermeasure
  • Transcriptomics
  • Microbial biochemistry
  • Chemical Science
  • Biomarkers


Host-pathogen interactions –  Mechanisms of pathogen virulence and host immunity

Therapeutics – Molecular strategies to defeat infectious disease

Cell and molecular biology – Advanced tools to investigate cellular behavior and physiology


Ph.D, Molecular and Cell Biology, MIT, Cambridge, MA, 1991 - 1997

BA, Biochemistry, Columbia University, NY, NY, 1987 - 1991


LANL Positions

Team Leader, Host-Pathogen Biology, LANL, 2009 - current 

Staff Scientist, LANL, 2003 - current 

Co-Editor, HIV/SIV Vaccine Trials Database, 2006 - 2007

Post-doctoral Associate, LANL, 2000 - 2003    


Professional Societies

Editorial Review Board, Frontiers in Microbial Immunology, 2012 - current



Interview with Santa Fe New Mexican on Host-Pathogen research, 11/3/2012

Featured in Genetic Engineering and Biotechnology News, OMICs section “Embattled RNAi Technology Tries New Tack”, 1/15/2012

Los Alamos Award Program (LAAP) in Exceptional Mentoring, 2010 

LANL/S&T Institutional Research Grant, 2003 - 2005 

American Cancer Society Post-doctoral Fellowship, 1997 - 2000 

NIH Post-doctoral Fellowship – National Research Service Award, 1997 

Association for Women in Science (AWIS) Educational Foundation Award, 1997    

NIH Graduate Traineeship, 1991 - 1997



USA US 07576183 -  Structure-based receptor mimics targeted against bacterial superantigen toxins, Goutam Gupta, Elizabeth Hong-Geller, Patrick Shiflett, and Nancy Lehnert



Hong-Geller E. (2013) Small-RNA-mediated regulation of host-pathogen interactions. Virulence. In preparation.

Stubben CJ, Micheva-Viteva S, Shou Y, Dunbar JM, and Hong-Geller E. (2013) Differential expression of small RNAs from Burkholderia thailandensis in response to environmental and stressful growth conditions. In preparation.

Shepherd DP, Li N, Micheva-Viteva S, Munsky B, Hong-Geller E, and Werner J. (2013)  Counting small RNA in pathogenic bacteria. Submitted.

Micheva-Viteva S, Shou Y, Nowak-Lovato K, Rector KD, and Hong-Geller E.  (2013) c-KIT-EGR1 signaling is targeted by Yersinia during infection.  Submitted.

Nowak-Lovato K, Alexandrov LB, Banisadr A, Bauer AL, Bishop AR, Usheva A, Mu F, Hong-Geller E, Rasmussen K, Hlavacek WS, and Alexandrov BS. (2013) Binding of Nucleoid-associated Protein Fis to DNA is Regulated by DNA Breathing Dynamics. PLoS Comp. Biol. Jan;9(1):e1002881. doi: 10.1371/journal.pcbi.1002881.

Marti-Arbona R, Teshima M, Anderson PS, Nowak-Lovato K, Hong-Geller E, Unkefer C, and Unkefer P. (2012) Identification of new ligands for the methionine biosynthesis transcriptional regulator (MetJ) by FAC-MS.  J. Mol Microbiol Biotech. 22: 205-214.

Novak-Lovato K, Hickmott AJ, Maity, TS, Bulyk ML, Dunbar J, and Hong-Geller E. (2012) DNA binding site analysis of Burkholderia thailandensis response regulators. J. Microbiol. Methods. 90:46-52.

Taylor-McCabe, K, Shou, Y, and Hong-Geller, E. (2012) Effects of Bacillus anthracis hydrophobicity and induction of host cell death on sample collection from environmental surfaces. J. Gen. Appl. Microbiology. 58: 113-119.

Maity, TS, Close, DW, Valdez, YE, Nowak-Lovato, K, Marti-Arbona, R, Nguyen, TT, Unkefer, PJ, Hong-Geller, E, Bradbury, AR, and Dunbar, JM (2012) Discovery of DNA operators for TetR and MarR family transcription factors from Burkholderia xenovorans. Microbiology. 158: 571-82.

Hong-Geller, E., Valdez, Y., Shou, Y., Yoshida, T., Marrone, B., and Dunbar, J. (2010)  Evaluation of B. anthracis and Y. pestis sample collection from nonporous surfaces by quantitative real-time PCR. Lett. Appl. Microbiol. 50: 431-7.

Hong-Geller, E. and Micheva-Viteva, S. (2010) Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection. Curr. Drug Discov. Technol. 7: 86-94.

Hong-Geller, E. (2009) A role for cell adhesion in beryllium-mediated lung disease. J. Occup. Environ. Hyg. 6: 727-731.

Lauer, S., Kunde, YA, Apodaca, TA, Goldstein, B., and Hong-Geller, E. (2009) Soluble MD2 increases TLR4 levels on the epithelial cell surface.  Cell. Immunol. 255: 8-16.

Rodriguez, S., Kunde, YA, McClesky, TM, and Hong-Geller, E. (2008) Upregulation of I-CAM1 in response to beryllium exposure in small airway epithelial cells. Toxicol. Lett. 179: 140-7.

Hong-Geller, E, Chaudhary, A. and Lauer, S. (2008) Targeting Toll-like receptor signaling pathways for design of novel immune therapeutics. Curr Drug Disc Tech. 5: 29-38.

Scott, BL., McCleskey, TM, Chaudhary, A., Hong-Geller, E, and Gnanakaran, S. (2008) The bioinorganic chemistry and associated immunology of chronic beryllium disease.  Chem. Commun. 25: 2837-47.

Hong-Geller, E., Pardington, P., Cary, R., Sauer, N., and Gupta, G. 2006. Chemokine regulation in response to beryllium exposure in human peripheral blood mononuclear and dendritic cells. Toxiciology. 218:216-28.

Hong-Geller, E., Molhoff, M. Shiflett, P.R., and Gupta, G. (2004) Design of chimeric receptor mimics with different TcRVb isoforms: type-specific inhibition of superantigen pathogenesis. J. Biol. Chem. 279:5676-5684.

Hong-Geller, E. and G. Gupta. 2003. Therapeutic approaches to superantigen-based diseases. J. Molec. Recog. 16:91-101.

Zhong, B., K. Jiang, D.L. Gilvary, P.K. Epling-Burnette, C. Ritchey, J. Liu, R.J. Jackson, E. Hong-Geller, and S. Wei. 2003. Human neutrophils utilize a Rac/Cdc42-dependent MAPK pathway to direct intracellular granule mobilization towards ingested microbial pathogens. Blood. 101:3240-3248.

Jiang, K., B. Zhong, B. Ritchey, D.L. Gilvary, E. Hong-Geller, S. Wei, and J.Y. Djeu. 2003. Regulation of AKT dependent cell survival by Syk and Rac. Blood. 101:236-44.

Jiang, K., Zhong, B., Gilvary, D.L., Corliss, B.C., Vivier, E., Hong-Geller, E., Wei, S. and J.Y. Djeu. 2002. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function. J. Immun. 168:3155-64.

Hong-Geller, E., D.A. Holowka, R.P. Siraganian, B.A. Baird, and R.A. Cerione. 2001. Activation of PLCg1 by Cdc42/Rac during mast cell degranulation. Proc. Natl Acad Sci. 98:1154-1159.

Hong-Geller, E., K. Field, J. Apgar, R.P. Siraganian, B.A. Baird, and D.A. Holowka. 2000. Mutant RBL mast cells defective in FceR1 signaling and lipid raft biosynthesis are reconstituted by activated Rho-family GTPases. Mol. Biol. Cell. 11:3661-3673.

Hong-Geller, E., and R. Cerione. 2000. Cdc42 and Rac stimulate exocytosis of secretory vesicles by activating the IP3/calcium pathway in RBL-2H3 mast cells. J.Cell Biol. 148: 481-494.

Jiang, K., B. Zhong, D.L. Gilvary, B.C. Corliss, E. Hong-Geller, S. Wei, and J.Y. Djeu. 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nature Immun. 1:419-425.

Hong, E., A.R. Davidson, and C.A. Kaiser. 1996. A pathway for targeting soluble misfolded proteins to the yeast vacuole. J.Cell Biol. 135:623-633.